Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bluebird Bio 60 BINNEY STREET CAMBRIDGE MA 02142 USA

P: 339-499-9300

Description:

Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 4,650,571
Shares Outstanding, K 55,331
Annual Sales, $ 54,580 K
Annual Net Income, $ -555,630 K
Last Quarter Sales, $ 8,910 K
Last Quarter Net Income, $ -206,030 K
60-Month Beta 2.16
% of Insider Shareholders 3.00%
Float, K 53,671
% Float 97.00%

Growth:

1-Year Return -16.14%
3-Year Return 18.05%
5-Year Return -8.64%
5-Year Revenue Growth 170.47%
5-Year Earnings Growth -428.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.73 on 10/31/19
Next Earnings Date 11/07/19
Earnings Per Share ttm -12.99
EPS Growth vs. Prev Qtr -5.07%
EPS Growth vs. Prev Year -36.63%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

BLUE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -13.27
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -42.29
Return-on-Assets (Before Tax) -34.48
Profit Margin % -1,018.01
Net Margin % N/A
Debt/Equity 0.11
Price/Sales 88.17
Price/Cash Flow N/A
Price/Book 3.27
Book Value/Share 26.60
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar